OSTEOPATHIC TRUSTS
Research into, and promotion of osteopathy. Providing osteopathic care to the public, independent of their ability to pay, and education for medical doctors in osteopathic principles and practice.
Financial health, per its FY2024 accounts
The accounts state that the charity achieved a surplus income over expenditure for the year ended 31 December 2024, continuing a trend of financial recovery from previous losses. The trustees report that the current policy of providing clinical services and renting out rooms is maintaining a balance between income and costs without drawing on reserves. Free unrestricted reserves stood at £248,691, which the trustees note is below their preferred level but deemed necessary given the charity's reliance on income as received.
What the accounts disclose
“Following extensive refurbishment and re-organisation over recent years the reserves of the charity were reduced below a level that the directors would have chosen.” — page 5
Property (HM Land Registry)
Register events
- Received assets from another charity (01/08/2018)
Trustees
- CATHERINE JANE SURRIDGEchair
- Dr Alan Allcock
- Dr Christopher Belshaw
- Dr John Tanner
- Dr Judith Mary Neaves
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £95k | £92k |
| 31/12/2023 | £118k | £94k |
| 31/12/2022 | £143k | £139k |
| 31/12/2021 | £146k | £177k |
| 31/12/2020 | £115k | £137k |
Common questions
Is OSTEOPATHIC TRUSTS financially healthy?
Per its FY2024 accounts: The accounts state that the charity achieved a surplus income over expenditure for the year ended 31 December 2024, continuing a trend of financial recovery from previous losses. The trustees report that the current policy of providing clinical services and renting out rooms is maintaining a balance between income and costs without drawing on reserves. Free unrestricted reserves stood at £248,691, which the trustees note is below their preferred level but deemed necessary given the charity's reliance on income as received. Its FY2024 accounts were independently examined.